Immunocore has raised more than $258m in an upsized offering and an additional $15m in a concurrent private placement.

Immunocore, a UK-based bispecific immunotherapy developer with roots at University of Oxford, issued approximately 9.94 million American Depositary Shares priced at $26 on Thursday to raise more than $258m in its IPO. The company concurrently completed a $15m private placement, for total proceeds of more than $273m. It issued an additional 1.8 million shares and…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.